... human blood (by analyzing it to measure metabolite levels) and the human body (by administering a thiopurine drug). Justice Breyer countered that the claims at issue required only that the metabolite ... issued “a very high 79 Id. at 20-22. 80 Id. at 23-24. 81 See Jeffrey L. Fox, “Industry Reels as Prometheus Falls and Myriad Faces Further Reviews,” 30 Nature Biotechnology no. 5 (May 2012), ... Office.93 More commonly known as Myriad—after the name of the patent holder—this litigation may determine whether patents may appropriately issue on isolated deoxyribonucleic acid (DNA) molecules...